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Available online 30 September 2016Eight RNA samples taken from the tracheobronchial lymphnodes (TBLN) of pigs thatwere either infected or non-
infectedwith a feral isolate of porcine pseudorabies virus (PRV)were used to investigate changes in gene expres-
sion related to the pathogen. The RNAwas processed into fastq ﬁles for each library prior to being analyzed using
Illumina Digital Gene Expression Tag Proﬁling sequences (DGETP)whichwere used as the downstreammeasure
of differential expression. Analyzed tags consisted of 21 base pair sequences taken from time points 1, 3, 6, and
14 days' post infection (dpi) that generated 1,927,547 unique tag sequences. Tag sequences were analyzed for
differential transcript expression and gene set enrichment analysis (GSEA) to uncover transcriptomic changes re-
lated to PRV pathology progression. In conjunction with the DGETP and GSEA, the study also incorporated use of
leading edge analysis to help link the TBLN transcriptome data to clinical progression of PRV at each of the sam-
pled time points. The purpose of this manuscript is to provide useful background on applying the leading edge
analysis to GSEA and expression data to help identify genes considered to be of high biological interest. The
data in the form of fastq ﬁles has been uploaded to the NCBI Gene Expression Omnibus (GEO) (GSE74473)
database..
ss article under the CC BY license (htPublished by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Keywords:
Gene expression
Pseudorabies virus
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Leading edge analysis
Speciﬁcations
Organism/cell line/tissue
Sus scrofa domesticus/tracheobronchial lymph
nodes (TBLN)
Sex
Male
Sequencer or array type
Illumina HiSeq 2000
Data format
Raw Digital Gene Expression Tag Proﬁling
sequences
Experimental factors
infected with feral isolate FS268 of
Pseudorabies virus vs. uninfected at 1, 3, 6,
and 14 dpi
Experimental features
Very brief experimental description
Consent
N/A
Sample source location
N/A1. Direct link to deposited data
Raw sequence data for this study is available at: http://www.ncbi.
nlm.nih.gov/geo/query/acc.cgi?acc=GSE74473.2. Experimental design, materials and methods
2.1. Experimental design
The experimental design used in the original study is described in
full in Miller et al., 2015 [1] and consisted of RNA isolation from por-
cine tracheobronchial lymph node (TBLN) tissue from infected and
non-infected pigs. Pathogen-free pigs, between 4 and 5 weeks of
age (N = 40) were split into two equal (n = 20) treatment groups
and received intranasal inoculations of either a sham inoculum or a
1 × 106 cell culture infectious dose (CCID50) of Pseudorabies virustp://creativecommons.org/licenses/by/4.0/).
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TBLNs were performed on necropsy days 1, 3, 6, and 14 dpi on ﬁve
pigs from each of the treatment groups and stored at −80 °C in
RNA later. Total RNA extractions were conducted using 1 g of TBLN
per pig in the MagMAX™-96 for Microarrays Total RNA Isolation
Kit (Applied Biosystems). RNA sample quality was veriﬁed by both
Bio-analyzer 2100 and RNA 6000 Nano-chip (Agilent Technologies)
and had an RNA integrity number (RIN) of 7.8 on average for the ex-
tracted samples and a 28S/18S ratio of 1.9.
2.2. Digital gene expression proﬁling and sequencing
Tag preparation and library construction was performed using the
Illumina DGETP DpnII sample prep kit. One milligram aliquots of total
RNAwere used in accordance to the sample kit protocols to ﬁrst isolate
the polyadenylated RNA leading to cDNA synthetization, DpnII diges-
tion, and GEX DpnII adaptor ligation to the 5′ end of the cDNA frag-
ments. Restriction sites 17 bp downstream from the adaptor were
then cleaved with MmeI and a second adaptor ligated to the tag site. A
15-cycle PCR using complimentary primers was used for ampliﬁcation
of the cDNA fragments. After elution from the gel, the DNA was precip-
itated using 10 μL of 3 M sodium acetate (pH 5.2) and 325 μL of ethanol
(−20 °C), centrifuged for 20 min (14,000 RPM) and washed with 70%
ethanol prior to resuspension in 10 μL of 10mMTris–HCl (pH 8.5). Qual-
ity was accessed using a Nanodrop 1000 spectrophotometer. Samples
were then sequenced using the Solexa/Illumina Genome Analyzer II to
generate a total of 8 raw fastq sequence ﬁles available in the public
repository Gene Expression Omnibus (GEO) (GSE74473).
3. Transcriptome analysis
Analysis of transcriptional data based on identiﬁcation and quantiﬁca-
tion of transcript tags for each transcriptional unit (TU)was carried out in
a four stepprocess. Step1utilized a customPerl script to identify andﬁlter
tagged transcripts into a 3 column list generated from the ﬁrst 20 bases of
the tag sequence, the raw tag count, and normalized tag counts. Normal-
ized tag counts were based upon total number of DEGTP tags for a TU di-
vided by the total number of TU counts for a tissue then normalized as
tags permillion (TPM). Step 2 computed the transcript abundances for in-
fected and non-infected samples quantiﬁcation using the Audic-Claverie
algorithm [2] that allows for calculation of the nominal p-values between
infected and control groups based upon Bayesian averaging to infer the
Poisson distribution of the tags. The Audic-Claverie algorithm was used
to compare the 2 groups as control vs. infected for each dpi. The values
for steps 1 and 2 were used as inputs for MatLab to calculate transcript
abundance. InMatLab, an FDRof ≤0.01was applied and tagged transcripts
showing a two-fold or greater increasewere considered to be differential-
ly expressed. The tags displaying differential expression were then
grouped using K-means clustering. Step 3 used the differential expression
and K-means clustering information to perform a ranked gene set enrich-
ment analysis (GSEA). A leading edge analysis was performed during this
step to elucidate key genes related to both the transcriptomic changes
and clinical signs related to PRV pathogenesis. Step 4 involved the visual-
ization of the data as hive plots. Hive plot creationwas used as a graphical
representation of the transcriptomic changeswitnessed in the PRV infect-
ed pigs and to allow for ameans to accomplish direct infected/non-infect-
ed comparisons. The plots are organized to allow for readers to observe
what genes are involved in which pathways and networks dependent
on the day post infection. The hive plots are created from the intersection
of the results for each dpi based upon the differentially expressed gene
transcripts, the gene position, and GSEA results.
3.1. Leading edge analysis
In order to determine which genes have the highest impact on the bi-
ological process under study, a portion of the GSEA was dedicated toperforming leading edge analysis of the differentially expressed genes.
The leading edge analysis allows for theGSEA to determinewhich subsets
(referred to as the leading edge subset) of genes contributed the most to
the enrichment signal of a given gene set's leading edge or core enrich-
ment [3]. The leading edge analysis is determined from the enrichment
score (ES), which is deﬁned as the maximum deviation from zero [1,3].
The analysis is accomplished by setting the GSEA software parameters
to deﬁne subsets of the core genes that drive the enrichment score of
the GSEA clusters. Step 1 of initiating the leading edge analysis is to select
the gene sets from the GSEA results that are to be compared. This can be
done by ranking the gene sets by an FDR cut-off. For our study this was
represented by the enriched gene sets for each of the dpi (1, 3, 6, 14). In
step 2, the GSEA software will output four graphs representing the over-
lapping subsets of the chosen gene sets (i.e. subsets for each dpi) from
step 1. The four graphs that are generated are: (a) Heat map which
shows the clusters and expression values for the leading edge subsets
color-coded to represent ranges from lowest to high (Fig. 1), (b) Set-to-
set graph that displays the overlap between the subsets in which the
number of genes shared between subsets is displayed as color intensity.
The intensity of the color is directly correlated to amount of overlap, (c)
Genes in subset list (Fig. 1) which is a simple graph of howmany subsets
in which a particular gene belongs. This can inform the researcher of key
candidate genes whose functions may be of biological interest. The last
graph (d) is a histogram showing the Jacquard, which gives the number
of subset occurrences binned by frequency. This will give information
on how many subset pairs share overlap. Step 3 gives the researcher the
ability to initiate the “Build HTML Report”whichwill give all of the details
for interpreting the leading edge analysis [4]. The genes that comprise a
leading edge subset have a high correlation between their expression
level and the phenotype in question and tend to be at the extremes of
the distribution, rather than randomly distributed. This subset is essen-
tially the genes within each cluster responsible for the enrichment score
for that cluster. This is based on several statistical values referred to as
the Tag, List, and Signal. The tag is the number of genes of the leading
edge subset that actively contribute to the enrichment score, the list
gives the position or rank of the genes, and the signal is the strength/in-
tensity of the genes. A keyuse of this GSEAmodule is to examine the over-
lap in enriched genes between groups. The comparison of the overlap can
be extended over time points to better understandwhat genes tend to be
involved at the core of the transcriptomic response during infection. In
our study, comparing the output from this analysis at each dpi allowed
for the ability to rank subsets by expression and enrichment level and
compare this to the daily progression of PRV clinical symptom pathology.
The combinatorial effect of the GSEA, DEG, and leading edge analysis out-
put gave our study means for observing what genes and which genetic
(transcriptomic) changes are reﬂected by the disease phenotype.4. Conclusion
Amajor goal of this study was to proﬁle the biological and molec-
ular networks involved in the pathological response caused by PRV
infected TBLN. The analysis pipeline that was used also gave the
study the ability to relate biological networks to the clinical progres-
sion of PRV observed in the animals at each dpi (1,3,6,14). Taken
along with the results from the leading edge analysis, the study
was able to provide data on which genes were being differentially
expressed but also allowed for the recognition of the number of
gene sets and key genes within those sets, whose expression varied
signiﬁcantly as PRV pathology progressed from 1 dpi to 14 dpi. Lead-
ing edge analysis was used to determine the genes that overlapped
between treatment groups and dpi's that contribute the greatest to
the transcriptomic response to PRV. These leading edge or core
genes are considered to be of high biological interest due to
appearing at higher frequencies among the subsets between
groups.
Fig. 1. Example from 1 dpi showing the graphs for the “Heatmap” and “Gene in Subsets” output from the leading edge analysismodule. Input is based on themotif gene set from the GSEA.
These leading edge analysis graphs were used in the current study to identify candidate genes possibly connecting clinical PRV signs to transcriptomic changes.
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